115 related articles for article (PubMed ID: 32633347)
1. VASN promotes proliferation of prostate cancer through the YAP/TAZ axis.
Cui FL; Mahmud AN; Xu ZP; Wang ZY; Hu JP
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6589-6596. PubMed ID: 32633347
[TBL] [Abstract][Full Text] [Related]
2. VASN promotes proliferation of laryngeal cancer cells via YAP/TAZ.
Liu H; Kong W; Wen S; Wu J; Yin X; Liu Y
J BUON; 2021; 26(4):1563-1570. PubMed ID: 34565020
[TBL] [Abstract][Full Text] [Related]
3. VASN promotes colorectal cancer progression by activating the YAP/TAZ and AKT signaling pathways via YAP.
Liang W; Zuo J; Liu M; Su Y; Guo B; Hou J; Xing Q; Peng Y; Fang L; Cao Y; Shan J; Sun R; Zhao J; Wang J
FASEB J; 2023 Jan; 37(1):e22688. PubMed ID: 36468780
[TBL] [Abstract][Full Text] [Related]
4. An Imbalance in TAZ and YAP Expression in Hepatocellular Carcinoma Confers Cancer Stem Cell-like Behaviors Contributing to Disease Progression.
Hayashi H; Higashi T; Yokoyama N; Kaida T; Sakamoto K; Fukushima Y; Ishimoto T; Kuroki H; Nitta H; Hashimoto D; Chikamoto A; Oki E; Beppu T; Baba H
Cancer Res; 2015 Nov; 75(22):4985-97. PubMed ID: 26420216
[TBL] [Abstract][Full Text] [Related]
5. The Hippo Pathway in Prostate Cancer.
Salem O; Hansen CG
Cells; 2019 Apr; 8(4):. PubMed ID: 31018586
[TBL] [Abstract][Full Text] [Related]
6. VASN promotes YAP/TAZ and EMT pathway in thyroid carcinogenesis in vitro.
Bhandari A; Guan Y; Xia E; Huang Q; Chen Y
Am J Transl Res; 2019; 11(6):3589-3599. PubMed ID: 31312369
[TBL] [Abstract][Full Text] [Related]
7. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.
Tan G; Cao X; Dai Q; Zhang B; Huang J; Xiong S; Zhang Yy; Chen W; Yang J; Li H
Oncotarget; 2015 Apr; 6(11):8676-86. PubMed ID: 25895125
[TBL] [Abstract][Full Text] [Related]
8. SAPCD2 promotes invasiveness and migration ability of breast cancer cells via YAP/TAZ.
Zhang Y; Liu JL; Wang J
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3786-3794. PubMed ID: 32329855
[TBL] [Abstract][Full Text] [Related]
9. Tissue inhibitor of metalloproteinase-1 promotes cell proliferation through YAP/TAZ activation in cancer.
Ando T; Charindra D; Shrestha M; Umehara H; Ogawa I; Miyauchi M; Takata T
Oncogene; 2018 Jan; 37(2):263-270. PubMed ID: 28925394
[TBL] [Abstract][Full Text] [Related]
10. USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ.
Zhu H; Yan F; Yuan T; Qian M; Zhou T; Dai X; Cao J; Ying M; Dong X; He Q; Yang B
Cancer Res; 2020 Jun; 80(11):2204-2216. PubMed ID: 32217697
[TBL] [Abstract][Full Text] [Related]
11. YAP and TAZ are distinct effectors of corneal myofibroblast transformation.
Muppala S; Raghunathan VK; Jalilian I; Thomasy S; Murphy CJ
Exp Eye Res; 2019 Mar; 180():102-109. PubMed ID: 30578787
[TBL] [Abstract][Full Text] [Related]
12. Suppression of YAP/TAZ-Notch1-NICD axis by bromodomain and extraterminal protein inhibition impairs liver regeneration.
Liu C; Cheng X; Chen J; Wang Y; Wu X; Tian R; Liu B; Ding X; Sun Q; Gong W
Theranostics; 2019; 9(13):3840-3852. PubMed ID: 31281517
[No Abstract] [Full Text] [Related]
13. Honokiol regulates ovarian cancer cell malignant behavior through YAP/TAZ pathway modulation.
Liu F; Zhang Y; Xia X; Han J; Cao L
J Obstet Gynaecol Res; 2024 Jun; 50(6):1010-1019. PubMed ID: 38576101
[TBL] [Abstract][Full Text] [Related]
14. Flow-dependent YAP/TAZ activities regulate endothelial phenotypes and atherosclerosis.
Wang KC; Yeh YT; Nguyen P; Limqueco E; Lopez J; Thorossian S; Guan KL; Li YJ; Chien S
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11525-11530. PubMed ID: 27671657
[TBL] [Abstract][Full Text] [Related]
15. SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis.
Lamar JM; Xiao Y; Norton E; Jiang ZG; Gerhard GM; Kooner S; Warren JSA; Hynes RO
J Biol Chem; 2019 Feb; 294(7):2302-2317. PubMed ID: 30559289
[TBL] [Abstract][Full Text] [Related]
16. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ
J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577
[TBL] [Abstract][Full Text] [Related]
18. Hyperglycaemia induces metabolic reprogramming into a glycolytic phenotype and promotes epithelial-mesenchymal transitions via YAP/TAZ-Hedgehog signalling axis in pancreatic cancer.
Liu Z; Hayashi H; Matsumura K; Ogata Y; Sato H; Shiraishi Y; Uemura N; Miyata T; Higashi T; Nakagawa S; Mima K; Imai K; Baba H
Br J Cancer; 2023 Mar; 128(5):844-856. PubMed ID: 36536047
[TBL] [Abstract][Full Text] [Related]
19. YAP, TAZ and AREG expression in eighth cranial nerve schwannoma.
Martini A; Marioni G; Zanoletti E; Cappellesso R; Stramare R; Fasanaro E; Faccioli C; Giacomelli L; Denaro L; D'Avella D; Mazzoni A; Fassina A
Int J Biol Markers; 2017 Jul; 32(3):e319-e324. PubMed ID: 28430338
[TBL] [Abstract][Full Text] [Related]
20. TAZ is overexpressed in prostate cancers and regulates the proliferation, migration and apoptosis of prostate cancer PC3 cells.
Lin M; Bu C; He Q; Gu J; Wang H; Feng N; Jiang SW
Oncol Rep; 2020 Aug; 44(2):747-756. PubMed ID: 32468018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]